APOE and breast cancer: IAXO-101 treatment also resulted in lower levels of Aβ plaques (Fig. 2N–P) and fibrillar amyloid deposits (Fig. 2Q–S), in both the CX and the HP, but no changes in Aβ (Fig. S3E, F) or apoE levels by BC analysis (Fig. S2G, H).